Interleukin-31 receptor A is a protein that in humans is encoded by the IL31RAgene.[1][2][3]
IL31RA is related to gp130 (IL6ST; MIM 600694), the common receptor subunit for IL6 (MIM 147620)-type cytokines. Oncostatin M receptor (OSMR; MIM 601743) and IL31RA form the heterodimeric receptor through which IL31 (MIM 609509) signals. Expression of IL31RA and OSMR mRNA is induced in activated monocytes, and both mRNAs are constitutively expressed in epithelial cells (Dillon et al., 2004).[supplied by OMIM][3]
References
↑Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA (Jun 2004). "Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice". Nat Immunol. 5 (7): 752–60. doi:10.1038/ni1084. PMID15184896.
↑Ghilardi N, Li J, Hongo JA, Yi S, Gurney A, de Sauvage FJ (May 2002). "A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5". J Biol Chem. 277 (19): 16831–6. doi:10.1074/jbc.M201140200. PMID11877449.
Diveu C, Lelièvre E, Perret D, et al. (2004). "GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor". J. Biol. Chem. 278 (50): 49850–9. doi:10.1074/jbc.M307286200. PMID14504285.
Dreuw A, Radtke S, Pflanz S, et al. (2005). "Characterization of the signaling capacities of the novel gp130-like cytokine receptor". J. Biol. Chem. 279 (34): 36112–20. doi:10.1074/jbc.M401122200. PMID15194700.
Diveu C, Lak-Hal AH, Froger J, et al. (2005). "Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling". Eur. Cytokine Netw. 15 (4): 291–302. PMID15627637.
Bilsborough J, Leung DY, Maurer M, et al. (2006). "IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis". J. Allergy Clin. Immunol. 117 (2): 418–25. doi:10.1016/j.jaci.2005.10.046. PMID16461143.